Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
From slowing production to tightening inspections, Boeing is reshaping how its jets are built as regulators keep a close ...
FOSHAN, GUANGDONG, CHINA, January 12, 2026 /EINPresswire.com/ -- Foshan AoChuanShun New Material Industrial Co., Ltd.
University of Kentucky professor argues design and circular economy principles are the foundation for effective manufacturing ...
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- As international demand for high-performance separation ...
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization ...
Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...
The EV industry appears to be stagnant these days, but under the surface, battery and EV tech development still advances at a ...
In future high-tech industries, such as high-speed optical computing for massive AI, quantum cryptographic communication, and ...
City utility provider JEA is reviewing a service request for a two-phase, 24/7 manufacturer that would use almost 1 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback